Hodgkin's disease in HIV-infected patients: Report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony-stimulating factor [2]

Annals of Oncology

Volumn 13, Issue 7, 2002, Pages 1158-1160

  Gastaldi, R ^a   Martino, P ^a   Gentile, G ^a   Picardi, V ^a   De Propris, M S ^a   Pirillo, M F ^b   De Vellis, A ^a   Mandelli, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; INDINAVIR; LAMIVUDINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; VINBLASTINE; ABVD PROTOCOL; ANTINEOPLASTIC AGENT;

ADULT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; NEUTROPENIA; PRIORITY JOURNAL; CASE REPORT; DOSE RESPONSE; DRUG ADMINISTRATION; EPIDEMIOLOGY; INTRAVENOUS DRUG ADMINISTRATION; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLEOMYCIN; CASE REPORT; DACARBAZINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HIV INFECTIONS; HODGKIN DISEASE; HUMAN; INFUSIONS, INTRAVENOUS; MALE; PROGNOSIS; RISK ASSESSMENT; SAMPLING STUDIES; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; TREATMENT OUTCOME; VINBLASTINE; HUMANS;

EID: 0035990844     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf239     Document Type: Letter

References (5)

1. Hodgkin's disease: Clinical presentation and treatment
2. Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: A prospective, clinical trials group study (ACTG 149)
3. Hodgkin's disease in 35 patients with HIV infection: An experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF
4. Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection
5. Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapy